FeesSafety
Pluang+

Ripple Prime enters leveraged ETF financing, offering stock swap funding for leveraged funds.

Market News
08 Oct 2026, 10:16 WIB
Crypto news
View Source
Neutral
Ripple Prime enters leveraged ETF financing, offering stock swap funding for leveraged funds.

Ripple Prime, Ripple's institutional brokerage arm, has started financing leveraged ETFs through stock swap arrangements, a service traditionally provided by major Wall Street banks. The firm finances funds like the Tradr 2X Long SNDK Daily ETF, charging a rate based on overnight bank funding costs plus four percentage points. This move expands Ripple's brokerage services beyond digital assets into equity derivatives and financing, supported by recent capital raises totaling $475 million. The development positions Ripple Prime as a growing player in institutional finance, although XRP's price showed little reaction to this expansion.

Ripple's new leveraged ETF financing push is the subject, with Pluang market data as of Oct 08, 2026 13:41 WIB. For readers following cryptocurrency trends, here is Pluang's market snapshot: out of 50 major cryptocurrencies, 10 rose and 39 fell today. XRP was priced at Rp25.033 with a 1-day change of -4.99%, a typical hold time of 71 days, and Pluang order activity showing 16% Sell and 84% Buy.

More News

Global music market to grow at 8.07% CAGR, reaching $57.74B by 2032 driven by streaming and digital access.

Global music market to grow at 8.07% CAGR, reaching $57.74B by 2032 driven by streaming and digital access.

The global music market is projected to grow from $36.13 billion in 2026 to $57.74 billion by 2032, at a CAGR of 8.07%, fueled by paid streaming subscriptions, smartphone adoption, and digital music discovery. North America remains the largest market...

Market News
Bullish
13 minutes ago
FDA grants orphan drug status to sovleplenib for rare autoimmune disease ITP treatment

FDA grants orphan drug status to sovleplenib for rare autoimmune disease ITP treatment

HUTCHMED announced that the US FDA has granted orphan drug designation to sovleplenib for treating primary immune thrombocytopenia (ITP), a rare autoimmune disorder causing low platelet counts and bleeding risks. This status provides benefits like 7 ...

Market News
Bullish
2 hours ago
China's coffee market to reach $8.04B by 2032, driven by cafe culture and specialty coffee growth.

China's coffee market to reach $8.04B by 2032, driven by cafe culture and specialty coffee growth.

China's coffee market is projected to grow from $5.8 billion in 2026 to $8.04 billion by 2032, at a CAGR of 5.54%. Growth is fueled by expanding chain cafes, specialty coffee methods like cold brew, and rising homegrown brands. However, rising coffee...

Market News
Neutral
2 hours ago
LUXEED hosts global media test drive showcasing advanced tech and luxury in new LLounge and Stormax models.

LUXEED hosts global media test drive showcasing advanced tech and luxury in new LLounge and Stormax models.

LUXEED held a global media test drive event at Chery's International Headquarters in Vu Hồ, featuring the luxury MPV LLounge and the high-performance Stormax SUV. Media representatives and influencers from UAE, Thailand, and Indonesia experienced a 1...

Market News
Bullish
2 hours ago
Law firm investigates NVE Corporation over sharp Q2 revenue drop and stock plunge.

Law firm investigates NVE Corporation over sharp Q2 revenue drop and stock plunge.

Kirby McInerney LLP is investigating NVE Corporation for possible violations of federal securities laws after the company reported a 47% revenue decline and a 33.7% stock price drop following its Q2 fiscal 2027 results. The revenue fall was attribute...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App